查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014991

醫學影像分析軟體市場：按組件、診斷影像方式、應用、部署類型和最終用戶分類－2026年至2032年全球市場預測

Medical Image Analysis Software Market by Component, Imaging Modality, Application, Deployment Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫學影像分析軟體市場價值將達到 26.1 億美元，到 2026 年將成長到 28 億美元，到 2032 年將達到 43.5 億美元，複合年成長率為 7.57%。

主要市場統計數據
基準年 2025 26.1億美元
預計年份：2026年 28億美元
預測年份 2032 43.5億美元
複合年成長率 (%) 7.57%

技術進步、臨床工作流程需求和監管期望如何匯聚，從而重新定義醫學影像分析工具的角色和應用路徑？

醫學影像分析領域正經歷快速發展，這主要得益於演算法能力的提升、資料編配的進步以及臨床工作流程的整合。近年來，深度學習架構和影像重建技術的進步顯著提高了各種成像方式的敏感度和特異性。同時，互通性標準和雲端原生技術的進步也使得影像設備、資訊平台和分析引擎之間的資料交換更加順暢。這種發展不僅限於技術層面，也受到臨床工作流程變化的驅動，例如放射科團隊日益重視基於價值的診療結果、診斷信心以及跨學科協作。

這是一個關鍵的技術、營運和監管轉折點，推動了從孤立的先導計畫向企業級整合醫學影像分析部署的轉變。

近年來，演算法開發、資料利用和企業部署模式的突破性變革共同提升了醫學影像分析的標準。在架構方面，融合了卷積神經網路、基於變壓器的注意力機制和特定任務微調的混合模式，顯著提高了模型在異質影像資料集上的泛化效能。同時，聯邦學習和隱私保護運算技術也日趨成熟，透過支援跨機構協作訓練模型而無需集中式資料池，有效解決了長期以來人們對資料管治和偏見的擔憂。

關稅政策的變化如何重塑硬體依賴型和軟體中心型影像分析解決方案的採購選擇、供應鏈韌性和供應商策略。

關稅調整和貿易政策轉變等政策措施會對醫學影像分析解決方案所需的影像設備、硬體加速器和周邊設備的供應鏈、籌資策略和價格趨勢產生顯著的下游影響。關稅若導致進口成像硬體、GPU 或專用感測器的成本增加，將促使買家重新評估籌資策略，盡可能加快在地採購，或優先考慮減少對特定硬體平台依賴的軟體架構。通常情況下，由於醫療系統和供應商需要協商修訂後的合約並評估新關稅制度下的總擁有成本，採購週期將會延長。

觀點出發，將組件、成像方式、臨床應用、部署模型和最終用戶需求連結起來，從而優先考慮開發和商業化。

一套精細的細分框架揭示了醫學影像分析領域中臨床需求、技術能力和商業性機會的交匯點。基於組件，市場細分為服務和軟體兩部分，二者各自擁有獨特的檢驗要求和持續的收入動態。服務著重於整合、標註和臨床檢驗，而軟體則著重於演算法開發、部署和生命週期管理。基於顯像模式，解決方案分為電腦斷層掃描 (CT)、磁振造影(MRI)、核子醫學影像、超音波和 X 光，每種影像方式特有的挑戰，例如重建偽影、時間解析度和劑量最佳化，都會影響演算法設計和臨床接受度。

美洲、歐洲、中東和非洲以及亞太地區的區域部署模式和監管細微差別決定了臨床檢驗、採購和規模化策略。

區域趨勢對醫學影像分析解決方案的採納路徑、臨床檢驗實務和商業化策略有顯著影響。在美洲，醫療保健系統通常優先考慮基於價值的醫療和臨床效用的證據，因此供應商需要透過深入的臨床研究和試驗計畫來證明其能夠改善治療效果並簡化工作流程。如果供應商能夠將產品功能與特定的營運挑戰結合，那麼完善的報銷機制和整合的醫療服務提供者網路可以加速企業級應用。

深入了解影像分析領域專業供應商、平台供應商和臨床整合商之間的競爭定位、夥伴關係策略和功能差異化。

醫學影像分析領域的競爭格局呈現出多元化的特點，包括專業分析供應商、大規模平台供應商和臨床服務整合商，它們在產品開發和商業化方面各有所長。專業分析供應商通常利用聚焦的臨床證據和快速迭代周期，憑藉在特定應用領域的深厚專業知識，促進早期臨床部署。平台提供者則憑藉其規模優勢、整合能力以及與醫療系統的成熟合作關係，實現更廣泛的部署和企業級互通性。服務整合商在連接技術解決方案與臨床工作流程方面發揮著至關重要的作用，為實際部署提供必要的標註、檢驗和變更管理服務。

為領導者提供切實可行的建議，以透過檢驗、可解釋性、穩健的部署和以臨床醫生為中心的商業策略來加速採用。

產業領導者應採取切實可行的、以證據為基礎的方法，在推動技術應用的同時，保護臨床和商業性投資。應優先進行嚴格的臨床檢驗，將演算法輸出與具體的流程改善和臨床醫生的決策點連結起來，確保試驗設計能夠衡量診斷信心、報告效率和後續臨床影響。同時，應投資於可解釋性和「人機互動」介面，以增強臨床醫生的信心，並支持上市前評估和上市後監測中的可解釋性。這些特性能夠顯著降低技術應用的門檻，並提高人們對分析結果效用的認知。

調查方法和多方面的研究設計，用於在影像分析中對臨床實踐、技術性能和監管考慮因素進行三角驗證。

本報告的研究採用多方面方法，旨在全面涵蓋醫學影像分析的技術、臨床和商業性層面。主要資訊來源包括對臨床負責人、影像科學家和採購主管的結構化訪談，以了解實際工作流程、證據需求和採購行為。技術評估利用演算法基準、同行評審文獻以及跨多種顯像模式的效能評估來衡量其通用性和穩健性。監管指導文件、臨床實踐指南和技術趨勢分析等輔助資料來源則補充了這些研究結果，以確保研究觀點的全面性。

總結醫學影像分析的成熟度，強調檢驗、互通性和生命週期管治是實現永續臨床影響的關鍵。

醫學影像分析正從實驗方法發展成為成熟的臨床工具，這些工具必須滿足嚴格的檢驗、互通性和管治標準。演算法進步、不斷變化的監管預期以及採購重點的轉變，共同創造了一種環境，在這種環境下，臨床證據和營運整合對於長期成功至關重要。投資於透明檢驗、以臨床醫生為中心的設計以及供應鏈韌性的機構，將更有能力將分析能力轉化為持久的臨床影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫學影像分析軟體市場：依組件分類

  • 服務
  • 軟體

第9章：依診斷影像方法分類的醫學影像分析軟體市場

  • 電腦斷層掃描
  • 磁振造影
  • 核醫學影像
  • 超音波
  • X光

第10章：醫學影像分析軟體市場：依應用領域分類

  • 癌症檢測
    • 乳癌
    • 肺癌
    • 攝護腺癌
  • 心血管影像
    • 心臟磁振造影分析
    • 冠狀動脈疾病的檢測
    • 超音波心臟檢查分析
  • 神經系統分析
  • 整形外科影像分析

第11章 醫學影像分析軟體市場：依部署模式分類

  • 雲
  • 現場

第12章 醫學影像分析軟體市場：依最終使用者分類

  • 學術研究機構
  • 診斷中心
  • 醫院
  • 診斷影像中心
  • 製藥和生物技術公司

第13章 醫學影像分析軟體市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫學影像分析軟體市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫學影像分析軟體市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療影像分析軟體市場

第17章：中國醫學影像分析軟體市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert NV
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hologic, Inc.
  • INFINITT Healthcare Co., Ltd.
  • Intelerad Medical Systems, Inc.
  • International Business Machines Corporation
  • Koninklijke Philips NV
  • Mirada Medical Limited
  • Sectra AB
  • Siemens Healthineers AG
Product Code: MRR-0363DFE03662

The Medical Image Analysis Software Market was valued at USD 2.61 billion in 2025 and is projected to grow to USD 2.80 billion in 2026, with a CAGR of 7.57%, reaching USD 4.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.61 billion
Estimated Year [2026] USD 2.80 billion
Forecast Year [2032] USD 4.35 billion
CAGR (%) 7.57%

How converging technological advances, clinical workflow demands, and regulatory expectations are redefining the role and adoption pathways of medical image analysis tools

The landscape of medical image analysis is experiencing a period of intense evolution driven by advances in algorithmic capability, data orchestration, and clinical workflow integration. Recent progress in deep learning architectures and image reconstruction techniques has improved sensitivity and specificity across a range of imaging modalities, while interoperability standards and cloud-native capabilities have enabled more seamless data exchange between imaging devices, informatics platforms, and analytic engines. This evolution is not isolated to technology alone; it occurs against a backdrop of changing clinical workflows, where radiology teams increasingly emphasize value-based outcomes, diagnostic confidence, and multidisciplinary collaboration.

Consequently, provider organizations are reassessing how imaging analytics are procured, validated, and deployed. Early clinical adopters emphasize rigorous validation, explainability of algorithmic outputs, and demonstrable impact on diagnostic workflows and patient outcomes. At the same time, payers and policy actors apply growing scrutiny to claims of improved outcomes and cost-effectiveness, further shaping adoption pathways. Taken together, these forces mean that stakeholders from vendors to hospital leaders must align technical innovations with clinical utility, regulatory compliance, and clear value propositions to realize the promise of next-generation imaging analytics.

Key technological, operational, and regulatory inflection points that are catalyzing a shift from isolated pilots to enterprise-grade integrated medical imaging analytics deployments

The last several years have brought transformative shifts across algorithm development, data practices, and enterprise deployment models that are collectively raising the bar for medical image analysis. Architecturally, hybrid models that integrate convolutional backbones with transformer-based attention and task-specific fine-tuning are delivering improved generalization across heterogeneous imaging datasets. Parallel to algorithmic innovation, federated learning and privacy-preserving computation have matured sufficiently to enable collaborative model training across institutions without centralized data pooling, thereby addressing long-standing concerns about data governance and bias.

Operationally, the industry is moving from proof-of-concept pilots to enterprise-grade deployments that emphasize interoperability with picture archiving and communication systems, electronic health records, and reporting workflows. This shift necessitates robust validation pathways, reproducibility of results, and mechanisms for continuous monitoring and model retraining. Regulatory frameworks are also evolving; guidance focused on software as a medical device and post-market surveillance is prompting vendors to adopt processes for risk management, performance monitoring, and explainability. Collectively, these trends are transforming medical imaging analytics from isolated point solutions into integrated components of diagnostic ecosystems, demanding greater cross-functional alignment among engineering, clinical, and commercial teams.

How shifts in tariff policy are reshaping procurement choices, supply chain resilience, and vendor strategies for hardware-dependent and software-centric imaging analytics solutions

Policy measures such as tariff adjustments and trade policy shifts can have material downstream effects on supply chains, sourcing strategies, and pricing dynamics for imaging equipment, hardware accelerators, and ancillary components essential to medical image analysis solutions. Tariffs that raise the cost of imported imaging hardware, GPUs, or specialized sensors incentivize buyers to reexamine procurement strategies, accelerate local sourcing where feasible, or prioritize software architectures that reduce reliance on specific hardware platforms. In many cases, procurement cycles lengthen as health systems and vendors negotiate revised contracts and assess total cost of ownership under new tariff regimes.

Beyond direct price effects, tariffs influence strategic decisions around localization, manufacturing footprint, and partnership formation. Vendors may opt to regionalize production or cloud deployment to mitigate exposure to cross-border duties, while service providers might expand managed services to absorb procurement complexity for end users. For imaging analytics specifically, a tariff environment that raises hardware costs can favor software-first solutions that emphasize modality-agnostic algorithms, lightweight inference on commodity processors, and cloud-based processing models. Ultimately, the cumulative outcome of tariff changes is a re-prioritization of product design, supply chain resilience, and commercial engagement models across the ecosystem.

A comprehensive segmentation perspective linking components, imaging modalities, clinical applications, deployment modes, and end-user needs to prioritize development and commercialization

A nuanced segmentation framework illuminates where clinical need, technical capability, and commercial opportunity intersect within medical image analysis. Based on Component, the landscape differentiates Services and Software, each with distinct validation requirements and recurring revenue dynamics; services focus on integration, annotation, and clinical validation while software concentrates on algorithm development, deployment, and lifecycle management. Based on Imaging Modality, solutions are organized across Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound, and X-Ray, with modality-specific challenges such as reconstruction artifacts, temporal resolution, and dose optimization shaping algorithm design and clinical acceptance.

Based on Application, clinical use cases range from Cancer Detection to Cardiovascular Imaging, Neurological Analysis, and Orthopedic Analysis; within Cancer Detection, targeted workflows address Breast Cancer, Lung Cancer, and Prostate Cancer, each requiring protocol-tailored models and validation cohorts. For Cardiovascular Imaging, subdomains such as Cardiac MRI Analysis, Coronary Artery Disease Detection, and Echocardiography Analysis demand distinct annotation schemas, temporal modeling approaches, and clinician-facing visualizations. Based on Deployment Mode, offerings span Cloud and On-Premises implementations, with trade-offs between latency, data residency, and scalability guiding adoption. Based on End User, solutions serve Academic And Research Institutes, Diagnostic Centers, Hospitals, Imaging Centers, and Pharmaceutical & Biotechnological Firms, each possessing unique procurement cycles, clinical workflows, and evidence expectations. By synthesizing these segmentation axes, stakeholders can prioritize technology investments, validation strategies, and go-to-clinical plans aligned to specific modality and end-user requirements.

Regional adoption patterns and regulatory nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine clinical validation, procurement, and scaling strategies

Regional dynamics exert a profound influence on adoption pathways, clinical validation practices, and commercialization strategies for medical image analysis solutions. In the Americas, health systems often emphasize value-based care and evidence of clinical utility, prompting vendors to demonstrate outcome improvements and workflow efficiencies through focused clinical studies and pilot programs. Reimbursement environments and consolidated provider networks can accelerate enterprise deployments where vendors align product capabilities with specific operational pain points.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization, data protection regimes, and variation in clinical infrastructure shape differentiated adoption. Pan-regional regulatory frameworks and national-level health priorities influence validation timelines and data sharing practices, encouraging partnerships with local clinical stakeholders to establish trust and relevance. In Asia-Pacific, rapid digitization, government-led initiatives to expand imaging capacity, and an increasing emphasis on domestic innovation create attractive conditions for scalable cloud-native solutions and public-private collaborations. Across all regions, successful strategies blend local clinical engagement, adaptable deployment models, and compliance with regional data governance standards to drive sustained adoption.

Insights into competitive positioning, partnership strategies, and capability differentiation among specialized vendors, platform providers, and clinical integrators in imaging analytics

Competitive dynamics in medical image analysis are characterized by a mix of specialized analytics vendors, larger platform providers, and clinical service integrators, each bringing complementary strengths to product development and commercialization. Specialized analytics vendors typically lead with focused clinical evidence and rapid iteration cycles, offering deep expertise in narrow applications that facilitate early clinical adoption. Platform providers contribute scale, integration capabilities, and established relationships with health systems, enabling broader distribution and enterprise-grade interoperability. Service integrators play a critical role in bridging technical solutions and clinical workflows, providing annotation, validation, and change-management services that are essential for real-world deployment.

Partnership strategies increasingly emphasize co-development with clinical institutions, certification pathways, and cloud partnerships to ensure scalability and compliance. Strategic alliances that combine clinical domain expertise, regulatory experience, and engineering capacity accelerate time-to-deployment and reduce friction in adoption. At the same time, new entrants are differentiating through niche clinical indications, improved model explainability, and performance on underrepresented cohorts. Together, these dynamics favor vendors who can demonstrate rigorous validation, transparent performance metrics, and robust post-deployment monitoring frameworks that align with institutional governance and clinician expectations.

Actionable recommendations for leaders to accelerate adoption through validation, explainability, resilient deployment, and clinician-centric commercial strategies

Industry leaders should adopt a pragmatic, evidence-led approach to advance adoption while protecting clinical and commercial investment. Prioritize rigorous clinical validation that aligns algorithmic outputs to tangible workflow improvements and clinician decision points, ensuring trials are designed to measure diagnostic confidence, reporting efficiency, and downstream clinical impact. In parallel, invest in explainability and human-in-the-loop interfaces that facilitate clinician trust and support interpretability during both pre-market evaluation and post-market surveillance. These capabilities materially reduce barriers to adoption and amplify the perceived utility of analytic outputs.

Additionally, supply chain and deployment decisions should be informed by resilience and flexibility. Embrace deployment architectures that allow hybrid cloud and on-premises inference to meet diverse data residency and latency requirements, while building modular software components to ease integration with existing PACS and EHR systems. Forge partnerships with clinical institutions for co-development and real-world performance monitoring, and establish transparent governance for bias mitigation and continuous model validation. From a commercial perspective, align pricing and contracting approaches with clinical validation pathways and outcomes-oriented value propositions to reduce procurement friction and encourage broader adoption across health systems.

Methodological foundations and multi-source research design used to triangulate clinical practice, technical performance, and regulatory considerations for imaging analytics

The research synthesis underpinning this report integrates a multi-source approach designed to capture technological, clinical, and commercial dimensions of medical image analysis. Primary inputs include structured interviews with clinical leaders, imaging scientists, and procurement executives to understand real-world workflows, evidence requirements, and purchasing behaviors. Technical assessments draw on algorithmic benchmarks, peer-reviewed literature, and performance evaluations across diverse imaging modalities to gauge generalizability and robustness. Secondary sources supplement these findings with regulatory guidance documents, clinical practice recommendations, and technology trend analyses to ensure a rounded perspective.

Methodologically, the work emphasizes triangulation across qualitative insights and technical performance data, with iterative validation of emergent themes through stakeholder workshops and scenario analyses. Ethical and governance considerations are incorporated by reviewing bias mitigation strategies, data governance best practices, and surveillance requirements. Wherever feasible, claims and conclusions are corroborated with multiple independent sources and cross-validated against clinician feedback to ensure practical relevance and reliability for decision-makers.

Concluding synthesis on the maturation of medical image analysis emphasizing validation, interoperability, and lifecycle governance as keys to sustainable clinical impact

Medical image analysis is undergoing a maturation from experimental techniques toward integrated clinical tools that must meet rigorous standards for validation, interoperability, and governance. The interplay of algorithmic advances, evolving regulatory expectations, and shifting procurement priorities is creating an environment where clinical evidence and operational integration determine long-term success. Organizations that invest in transparent validation, clinician-centric design, and supply chain resilience will be better positioned to translate analytic capability into sustained clinical impact.

Looking ahead, continuous monitoring and lifecycle management of deployed models will become non-negotiable as institutions demand reproducibility and equitable performance across patient populations. Strategic alignment between technical teams, clinical champions, and procurement stakeholders will accelerate adoption and scale. Ultimately, the technologies that succeed will be those that demonstrably improve diagnostic confidence, streamline workflows, and integrate seamlessly into the clinical fabric of imaging services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Image Analysis Software Market, by Component

  • 8.1. Services
  • 8.2. Software

9. Medical Image Analysis Software Market, by Imaging Modality

  • 9.1. Computed Tomography
  • 9.2. Magnetic Resonance Imaging
  • 9.3. Nuclear Imaging
  • 9.4. Ultrasound
  • 9.5. X-Ray

10. Medical Image Analysis Software Market, by Application

  • 10.1. Cancer Detection
    • 10.1.1. Breast Cancer
    • 10.1.2. Lung Cancer
    • 10.1.3. Prostate Cancer
  • 10.2. Cardiovascular Imaging
    • 10.2.1. Cardiac Mri Analysis
    • 10.2.2. Coronary Artery Disease Detection
    • 10.2.3. Echocardiography Analysis
  • 10.3. Neurological Analysis
  • 10.4. Orthopedic Analysis

11. Medical Image Analysis Software Market, by Deployment Mode

  • 11.1. Cloud
  • 11.2. On-Premises

12. Medical Image Analysis Software Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals
  • 12.4. Imaging Centers
  • 12.5. Pharmaceutical & Biotechnological Firms

13. Medical Image Analysis Software Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Image Analysis Software Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Image Analysis Software Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Image Analysis Software Market

17. China Medical Image Analysis Software Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agfa-Gevaert N.V.
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Fujifilm Holdings Corporation
  • 18.8. General Electric Company
  • 18.9. Hologic, Inc.
  • 18.10. INFINITT Healthcare Co., Ltd.
  • 18.11. Intelerad Medical Systems, Inc.
  • 18.12. International Business Machines Corporation
  • 18.13. Koninklijke Philips N.V.
  • 18.14. Mirada Medical Limited
  • 18.15. Sectra AB
  • 18.16. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIAC MRI ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIAC MRI ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIAC MRI ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ECHOCARDIOGRAPHY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ECHOCARDIOGRAPHY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ECHOCARDIOGRAPHY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NEUROLOGICAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NEUROLOGICAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY NEUROLOGICAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ORTHOPEDIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ORTHOPEDIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ORTHOPEDIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGICAL FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGICAL FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGICAL FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 160. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 161. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 184. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 185. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. G7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 192. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 193. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY CARDIOVASCULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)